CHIODERA, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 9.737
AS - Asia 7.443
EU - Europa 5.789
SA - Sud America 994
AF - Africa 316
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 12
AN - Antartide 1
Totale 24.311
Nazione #
US - Stati Uniti d'America 9.445
SG - Singapore 2.988
CN - Cina 2.534
FI - Finlandia 1.239
IE - Irlanda 1.124
SE - Svezia 911
DE - Germania 869
BR - Brasile 787
HK - Hong Kong 595
UA - Ucraina 568
TR - Turchia 469
VN - Vietnam 467
NL - Olanda 282
IT - Italia 275
ZA - Sudafrica 251
CA - Canada 233
GB - Regno Unito 123
IN - India 103
RU - Federazione Russa 84
FR - Francia 80
AR - Argentina 78
BE - Belgio 50
BD - Bangladesh 48
EC - Ecuador 40
PL - Polonia 40
IQ - Iraq 38
MX - Messico 37
ES - Italia 29
JP - Giappone 28
AT - Austria 23
IR - Iran 22
VE - Venezuela 21
CI - Costa d'Avorio 18
EU - Europa 18
LT - Lituania 18
PK - Pakistan 18
UZ - Uzbekistan 17
CL - Cile 16
ID - Indonesia 15
PE - Perù 15
AZ - Azerbaigian 14
CO - Colombia 14
PY - Paraguay 14
MA - Marocco 12
EG - Egitto 11
KR - Corea 11
SA - Arabia Saudita 10
CZ - Repubblica Ceca 9
IL - Israele 9
NO - Norvegia 9
AU - Australia 8
MY - Malesia 8
AL - Albania 7
HU - Ungheria 7
KE - Kenya 7
LU - Lussemburgo 7
RO - Romania 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
PA - Panama 5
PH - Filippine 5
BG - Bulgaria 4
BH - Bahrain 4
JO - Giordania 4
KZ - Kazakistan 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
OM - Oman 4
PT - Portogallo 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
AO - Angola 3
BO - Bolivia 3
DK - Danimarca 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
CH - Svizzera 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NG - Nigeria 2
PS - Palestinian Territory 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
IM - Isola di Man 1
IS - Islanda 1
KW - Kuwait 1
LV - Lettonia 1
Totale 24.294
Città #
Singapore 1.483
Ashburn 1.350
Chandler 1.284
Jacksonville 1.156
Dublin 1.122
Santa Clara 740
Beijing 720
Dallas 613
Hong Kong 595
Dearborn 440
Izmir 439
Nanjing 338
San Mateo 254
Boardman 251
Johannesburg 239
Princeton 234
Toronto 178
Ho Chi Minh City 172
Shanghai 170
Munich 140
Ann Arbor 138
Los Angeles 133
Des Moines 132
Nanchang 127
Shenyang 119
Düsseldorf 116
Wilmington 108
Helsinki 107
Kunming 103
Hanoi 101
Woodbridge 76
Columbus 74
New York 72
Hebei 69
Jinan 66
São Paulo 58
Hefei 57
Buffalo 56
Moscow 56
Tianjin 54
Brussels 50
Leawood 48
Grafing 47
Guangzhou 45
Turku 44
Parma 38
Seattle 38
Changsha 37
Jiaxing 37
London 33
Warsaw 31
Redondo Beach 30
Haiphong 28
Tokyo 27
Brooklyn 26
Hangzhou 26
Rome 25
Campinas 24
Falkenstein 24
Pune 23
Zhengzhou 23
Augusta 21
Chicago 21
Monmouth Junction 21
Phoenix 21
Chennai 20
Rio de Janeiro 20
Abidjan 18
Bremen 17
Da Nang 17
Atlanta 16
Fremont 16
Fuzhou 16
Hải Dương 16
Ottawa 16
Stockholm 16
Ardabil 15
Belo Horizonte 15
Denver 15
Nuremberg 14
Poplar 14
Taizhou 14
Baghdad 13
Biên Hòa 13
Borås 13
Dhaka 13
Kocaeli 13
Porto Alegre 13
Tashkent 13
Vienna 13
Boston 12
Norwalk 12
Quito 12
Recife 12
Amsterdam 11
Baku 11
Montreal 11
Mumbai 11
San Francisco 11
Taiyuan 11
Totale 15.021
Nome #
Different effects of aging on the opioid mechanisms controlling gonadotropin and cortisol secretion in man. 353
Livelli di prolattina, deidroepiandrosterone solfato, cortisolo, testosterone e 17-beta-estradiolo nell'alcolismo cronico. 170
Gonadotropine, prolattina e tireotropina nella S. di Klinefelter. 156
Inhibition by somatostatin of LH-RH-induced LH release in normal menstruating women. 155
5-HT3 serotonergic receptor mediation of hypoglycemia-induced arginine-vasopressin but not oxytocin secretion in normal men. 149
Inhibitory effect of somatostatin on the NPY response to insulin-induced hypoglycemia and the role of endogenous opioids 148
Protein Kinase Cε Regulates Proliferation and Cell Sensitivity to TGF-1β of CD4+ T Lymphocytes: Implications for Hashimoto Thyroiditis 147
Alpha2-adrenergic and histamine H1 and H2-receptors do not mediate arginine-vasopressin release in response to insulin induced hypoglycemia in man. 142
5HT1-, but not 5HT2- serotonergic or M1-, M2-muscarinic cholinergic or dopaminergic receptors mediate the ACTH/cortisol response to metoclopramide. 140
Arginine vasopressin secretion in non obese women with polycystic ovary syndrome. 140
Glucagon response to insulin-induced hypoglycemia in obese men. 139
Oxytocin reduces angiotensin II-induced ACTH release in men. 138
Abnormal arginine vasopressin response to cigarette smoking and metoclopramide, but not insulin induced hypoglycemia in elderly subjects. 138
Effect of muscarinic and nicotinic-cholinergic blockade on the glucagon response to insulin-induced hypoglycemia in normal men. 137
ADRENOCORTICOTROPIC HORMONE/CORTISOL RESPONSE TO PHYSICAL EXERCISE IN ABSTINENT ALCOHOLIC PATIENTS 137
Oxytocin administration does not alter growth hormone response to insulin induced hypoglycemia in normal men. 136
Studio parallelo di gonadotropine e prolattina in pazienti amenorroiche. 136
Different effect of metoclopramide and domperidone on GH release in type 1 male diabetics. 134
Abnormal growth hormone and cortisol but not thyroid stimulating hormone response to an intravenous glucose tolerance test in normal weight bulimic women. 134
Age-related decreased in the opioid control of LH secretion during reproductive years in normal men. 133
Naloxone decreases the inhibitory effect of somatostatin on GH release induced by cigarette smoking in man 133
The growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics involves a cholinergic mechanism. 132
Abnormal plasma oxytocin and b-endorphin levels in alcoholics after short and long-term abstinence. 132
: Beta-endorphin, ACTH and cortisol secretion rhythms in abstinent alcoholics. 132
The infusion of somatostatin reduces the arginine vasopressin response to insulin induced hypoglycemia in man. 132
Sugli effetti di un trattamento policorticoide su gonadotropine, PRL e TSH (valori basali e risposta ipofisaria). 132
Alterazione del controllo oppioide delle gonadotropine, ma non del cortisolo nell'uomo anziano. 131
Abnormal arginine vasopressin responses to metoclopramide and insulin induced hypoglycemia in type I diabetes mellitus. 129
Considerazioni sul comportamento della prolattina nelle displasie prostatiche. 128
Age-related changed in growth hormone (GH) secretion in normally cycling women. 127
Dopaminergic, but not cholinergic involvement in regulation of hypoglycemia-induced oxytocin release in man. 127
Lysine-vasopressin inhibits the effect of oxytocin on the insulin response to glucose in normal man. 127
Histaminergic H1 and H2 receptors do not mediate cortisol release in response to naloxone in normal men. 126
Different effects of baclofen on LH and cortisol responses to naloxone in normal men. 126
Effect of oxytocin on growth hormone (GH) secretion in response to arginin-vasopressin. 125
Comportamento del settore gonadotropinico nella patologia espansiva diencefalo-ipofisaria prima e dopo trattamento neurochirurgico. 125
GLUCORECEPTORS LOCATED IN THE BRAIN MEDIATE NPY RELEASE INDUCED BY HYPOGLICEMIA IN NORMAL MEN 124
Gonadotropins, prolactin and thyrotropin (basal value and pituitary responses) in infertile male patients. 124
Effect of serotonergic system on AVP secretion induced by physical exercise 124
Iperresponsività nell'anziano dell'arginin-vasopressina a stimolazione con fumo di sigaretta o con metoclopramide, ma non con ipoglicemia insulinica. 123
Arginine Vasopressin and Oxytocin responses to angiotensin II are mediated by AT1 receptor subtype in normal men 123
Effect of lysine vasopressin on basal and TRH stimulated TSH and PRL release in normal men. 123
Iperresponsività nell'anziano dell'arginin-vasopressina a stimolazione con fumo di sigaretta o con metoclopramide, ma non con ipoglicemia insulinica. 123
TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration. 122
Intravenously infused Substance P is unable to change basal and TRH-stimulated PRL secretion in normal men. 122
Effect of potentiation of cholinergic tone by pyridostigmine on the growth hormone (GH) response to GH-releasing hormone in elderly men. 122
Stimulatory effect of naloxone on plasma cortical in humans: possible direct stimulatory action at the adrenal cortex. 122
Increased Arginine-Vasopressin Response to Hypertonic Stimulation and Upright Posture in Idiopathic Hyperprolactinemia 121
LH, FSH, TSH and PRL (basal values and pituitary responses) in oligo- and azospermic patients. 121
ACTH and Beta-Endorphin responses to physical exercise in adolescent women tested for anxiety and frustration 121
Influenza dell'età sulla responsività ipofisaria GH- e ACTH-secernente alla lisin vasopressina. 121
Alterata risposta secretiva del GH allo stimolo GABAergico nel morbo di Parkinson. 121
Effect of naloxone on the inhibitory effect of melatonin on the release of arginine-vasopressin induced by physical exercise in man 120
Alteration in dopaminergic function in abstinent alcoholics. 119
Cholinergic mediation of growth hormone secretion induced by thyrotropin-releasing hormone in cirrhotic patients. 119
Lysine-vasopressin does not affect basal and LH-RH stimulated LH and FSH release during the menstrual cycle of normal women. 119
Growth hormone responses to GHRH, clonidine and insulin-induced hypoglycemia in normal weight bulimic women. 119
Effect of Naloxone on the LH response to intravenously-infused substance P in normal men 118
Failure of metergoline to antagonize naloxone induced cortisol rise in man. 118
Effect of metoclopramide on serum GH levels in normal women. 116
Influence of residual C-peptide secretion on the arginine-vasopressin response to hypoglycemia and metergoline in insulin-dependent diabetes. 116
Cholinergic- muscarinic-receptors participate in growth hormone secretion induced by lysine-8-vasopressin in man. 116
La somministrazione endovenosa di ossitocina non determina variazioni nelle concentrazioni di prolattina, TSH e GH in un gruppo di soggetti di sesso maschile. 115
Effect of cimetidine on PRL secretion in elderly subjects. 115
Circadian vairiations in plasma ACTH, cortisol and beta-endorphin levels in normal weight bulimic women. 115
Endogenous opioid mediation of the inhibitory effect of ethanol on the prolactin response to breast stimulation in normal women. 114
Risposta di TSH e PRL al TRH nella patologia nodulare tiroidea 114
Effect of naloxone on oxytocin-induced cortisol decrease in normal men. 114
Effect of systemic oxytocin administration on dexamethasone-induced leptin secretion in normal and obese men. 114
Arginine-vasopressin (AVP) responses to osmotic, pressure-volumetric and hypoglycemic stimuli in women with polycistic ovaries (PCO) 114
Nicotinic-cholinergic involvement in arginine-vasopressin response to insulin-induced hypoglycemia in normal men. 113
Naloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercice in man 113
Blunted GH response from cigarette smoking in four week abstinent alcoholics. 113
Effect of pharmacological doses of oxytocin on insulin response to glucose in man. 113
Gn-RH test for hypogonadic men. 112
Oxytocin does not modify glucagon- or calcitonin induced ACTH/Cortisol rise in humans. 112
Risposta del GH alla metoclopramide in corso di diabete mellito insulino-dipendente. 112
Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycemia in insulin-dependent diabetics. 112
Patologia espansiva ipotalamo-ipofisaria: studio parallelo di TSH e PRL. 112
Hypoglycemia induced arginine vasopressin and oxytocin release is mediated by glucoreceptors located inside the blood brain barrier 112
Abnormal effect of cigarette smoking on pituitary hormone secretions in insulin-dependent diabetes mellitus. 111
Effect of nitric oxide on basal and TRH- or metoclopramide-stimulated prolactin release in normal men 111
The gabaergic control of prolactin release is not affected by insulin-dependent diabetes mellitus: evidence from studies with sodium valproate. 111
Inhibition by oxytocin of Endothelin-1-induced ACTH secretion in normal men. 110
Oxytocin does not modify the PRL response to metoclopramide in normal women. 110
Reduction of lysine vasopressin induced GH, but not ACTH release in elderly men. 110
Age-dependent decrease in the growth hormone (GH) response to GH releasing hormone in normally cicling women. 109
Effect of naloxone on neurophysin secretion in normal women. 109
Naloxone abolishes the inhibiting effect of somatostatin on the release of oxytocin evoked by insulin-induced hypoglycemia in men. 109
Inhibition of growth hormone secretion in mild primary hyperparathyroidism 108
Effect of naloxone on somatostatin inhibition of arginine vasopressin response to physical exercise in normal men 108
Endogenous opioids modulate the oxytocin response to insulin induced hypoglycaemia and partially mediate the inhibitory effect of ethanol in man. 108
TSH and PRL responses to metoclopramide and TRH in normal elderly men. 108
Luteinizing hormone and cortisol responses to naloxone in normal weight women with bulimia. 108
Somatostatin reduces Neuropeptide Y rise induced by physical exercise. 107
Reduction of nomifensine-induced growth hormone release in elderly men. 107
I fattori regolatori della secrezione di vasopressina. 107
Livelli ematici di testosterone in corso di iperprolattinemia funzionale ed organica. 107
Dopaminergic and opioid receptor antagonist do not modify the secretory response of growth hormone to lysine-vasopressin in normal subjects. 107
Inhibitory effect of dexamethasone on arginine-vasopressin release induced by physical exercise in man 107
Totale 12.474
Categoria #
all - tutte 84.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.917


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021935 0 0 0 0 0 1 39 7 389 23 456 20
2021/20221.127 7 28 4 19 23 56 168 208 53 81 63 417
2022/20234.136 460 403 299 318 310 502 19 285 1.408 17 91 24
2023/20241.405 88 170 23 42 106 234 43 365 33 40 119 142
2024/20254.643 86 272 367 230 480 695 30 206 474 427 407 969
2025/20266.007 1.131 828 1.320 896 1.696 136 0 0 0 0 0 0
Totale 24.338